Claudin-3 Overexpression Increases the Malignant Potential of Colorectal Cancer Cells: Roles of ERK1/2 and PI3K-Akt as Modulators of EGFR signaling

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  de Souza, Waldemir F ^a   Fortunato Miranda, Natalia ^a   Robbs, Bruno K ^a   de Araujo, Wallace M ^a   de Freitas Junior, Julio C ^a   Bastos, Lilian G ^a   Viola, João P B ^a   Morgado Díaz, José A ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CLAUDIN 3; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; COLON CARCINOGENESIS; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH CARCINOGENESIS; TIGHT JUNCTION; TUMOR GROWTH; TUMOR PROMOTION; UPREGULATION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLAUDIN-1; CLAUDIN-3; COLORECTAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR STEM CELL ASSAY;

EID: 84884400041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074994     Document Type: Article

References (50)

1. Cereijido M, Contreras RG, Shoshani L, Florez-Benitez D, Larre I, (2008) Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biphys Acta 1778: 770-793.
2. Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, et al. (2011) Predicted expansion of the claudin multigene family. FEBS Lett 585: 606-612.
3. Takizawa Y, Kishimoto H, Kitazato T, Tomita M, Hayashi M, (2012) Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion. Int J Pharm 426: 82-89.
4. Ikari A, Takiguchi A, Atomi K, Sugatani J, (2011) Epidermal growth factor increases clathrin-dependent endocytosis and degradation of claudin-2 protein in MDCK II cells. J Cell Physiol 226: 2448-2456.
5. Asaka M, Hirase T, Hashimoto-Komatsu A, Node K, (2011) Rab5a-mediated localization of claudin-1 is regulated by proteasomes in endothelial cells. Am J Physiol Cell Physiol 300: C87-C96.
6. Yoon CH, Kim MJ, Park MJ, Park IC, Hwang SG, et al. (2010) Claudin-1 acts through c-Abl-protein kinase C delta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem 285: 226-233.
7. Lafky JM, Wilken JA, Baron AT, Maihle NJ, (2008) Clinical implications of the ErB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 1785: 232-265.
8. Vivekanand P, Rebay I, (2006) Intersection of signal transduction pathways and development. Annu Rev Genet 40: 139-157.
9. Ciardiello F, Tortora G, (2008) EGFR antagonistis in cancer treatment. N Engl J Med 358: 1160-1174.
10. de Araújo WM, Vidal FC, de Souza WF, de Freitas JC Jr, de Souza W, et al. (2010) PI3K-Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells. J Cancer Res Clin Oncol 136: 1773-1782.
11. Ma C, Wang J, Gao Y, Gao TW, Chen G, et al. (2007) The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res 67: 7756-7764.
12. Yoon YK, Kim HP, Han SW, Hur HS, Oh do Y, et al. (2009) Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells. Mol Cancer Ther 8: 2526-2536.
13. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, et al. (2006) Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532-C1542.
14. Singh AB, Harris RC, (2004) Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in madin-darby canine kidney cells. J Biol Chem 279: 3543-3552.
15. Singh AB, Sugimoto K, Dhawan P, Harris RC, (2007) Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am J Physiol Cell Physiol 293: C1660-C1668.
16. Ikari A, Takiguchi A, Atomi K, Sato T, Sugatani J, (2011) Decrease in claudin-2 expression enhances cell migration in renal epithelial Madin-Darby canine kidney cells. J Cell Physiol 226: 1471-1478.
17. Ikari A, Sato T, Watanabe R, Yamazaki Y, Sugatani J, (2012) Increase in claudin-2 expression by an EGFR/MEK1/2-ERK1/2/c-Fos pathway in lung adenocarcinoma A549 cells. Biochim Biophys Acta 1823: 1110-1118.
18. Peter Y, Comellas A, Levantini E, Ingenito EP, Shapiro SD, (2009) Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: implications for non-small cells lung cancer tumor colonization. Mol Carcinog 48: 488-497.
19. Oliveira SS, Oliveira IM, Souza W, Morgado-Díaz JA, (2005) Claudins upregulation in human colorectal cancer. FEBS Letters 579: 6179-6185.
20. Kinugasa T, Akagi Y, Ochi T, Tanaka N, Kawahara A, et al. (2012) Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. Anticancer Res 32: 2309-2314.
21. Ersoz S, Mungan S, Cobanoglu U, Turgutalp H, Ozoran Y, (2011) Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. Pathol Res Pract 207: 285-289.
22. Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, et al. (2011) Claudin-2 expression increases tumorigenicity of colon cancer cells: role of growth factor receptor activation. Oncogene 30: 3234-3247.
23. de Freitas Junior JC, Silva Bdu R, de Souza WF, de Araújo WM, Abdelhay ES, et al. (2011) Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells. Cancer Chemother Pharmacol 68: 227-238.
24. Mariadason JM, Rickard KL, Barkla DH, Augenlicht LH, Gibson PR, (2000) Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J Cell Physiol 183: 347-354.
25. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, et al. (2005) The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21: 1-26.
26. Halder SK, Beauchamp RD, Datta PK, (2005) A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7: 509-521.
27. Barbosa LA, Goto-Silva L, Redondo PA, Oliveira S, Montesano G, et al. (2003) TPA-induced signal transduction: a link between PKC and EGFR signaling modulates the assembly of intercellular junctions in Caco-2 cells. Cell Tissue Res 312: 319-31.
28. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S, (1998) Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to ocludin. J Cell Biol 141: 1539-1550.
29. Morita K, Furuse M, Fujimoto K, Tsukita S, (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 96: 511-516.
30. Chicaybam L, Sodre A, Curzio BA, Bonamino M, (2013) An efficient low cost method for gene transfer to T lymphocytes. Plos One 8: e60298.
31. Leve F, Marcondes TG, Bastos LG, Rabello SV, Tanaka MN, et al. (2011) Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells. Eur J Pharmacol 671: 7-17.
32. Contreras RG, Flores-Maldonado C, Lázaro A, Shoshani L, et al. (2004) Ouabain binding to Na+,K+-ATPase relaxes cell attachment and sends a specific signal (NACos) to the nucleus. J Membr Biol 198: 147-58.
33. Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ Jr, et al. (2001) Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 12: 279-295.
34. Vidal F, de Araujo WM, Cruz AL, Tanaka MN, Viola JP, et al. (2011) Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells. Int J Oncol 38: 1365-1373.
35. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP, (2008) Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28: 7168-7181.
36. Ohmori K, Kawamura Y, (2009) Cell transformation activities of abietic acid and dehydroabietic acid: safety assessment of possible contaminants in paper and paperboard for food contact use. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 26: 568-573.
37. Marcial MA, Madara JL, (1987) Analysis of absorptive cell occluding junction structure-function relationships in a state of enhanced junctional permeability. Lab Invest 56: 424-434.
38. Bezdekova M, Brychtova S, Sedlakova E, Langova K, Brychta T, et al. (2012) Analysis of snail-1, E-cadherin and claudin-1 expression in colorectal adenomas and carcinomas. Int J Mol Sci 13: 1632-1643.
39. Ogawa M, Kojima T, Someya M, Nomura K, Takasawa A, et al. (2012) Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines. Histochem Cell Biol 138: 323-338.
40. Oliveira SS, Morgado-Díaz JA, (2007) Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 64: 17-28.
41. de-Freitas-Junior JC, Bastos LG, Freire-Neto CA, Rocher BD, Abdelhay ES, et al. (2012) N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells. J Cell Biochem 113: 2957-2966.
42. Agarwal R, D'Souza T, Morin PJ, (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385.
43. Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, et al. (2010) Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis 31: 974-983.
44. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, et al. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776.
45. Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, et al. (2011) Claudin-1 upregulates the repressor ZEB-1 to inhibit E-Cadherin expression in colon cancer cells. Gastroenterology 141: 2140-2153.
46. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A, (1988) Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res 48: 1936-1942.
47. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE, (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18: 511-5118.
48. Mitchell LA, Overgaard CE, Ward C, Margulies SS, Koval M, (2011) Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function. Am J Physiol Lung Cell Mol Physiol 301: L40-49.
49. Hashimoto K, Oshima T, Tomita T, Kim Y, Matsumoto T, et al. (2008) Oxidative stress induces gastric epithelial permeability through claudin-3. Biochem Biophys Res Commun 376: 154-157.
50. Weber CR, (2012) Dynamic properties of the tight junction barrier. Ann N Y Acad Sci 1257: 77-84.